(Q37870798)

24 August 2017

1 reference

title

Migraine with aura: conventional and non-conventional treatments (English)

1 reference

24 August 2017

1 reference

1 reference

Giovanni D'Andrea

1

1 reference

24 August 2017

Davide Colavito

series ordinal

2

1 reference

24 August 2017

Maurizio Dalle Carbonare

series ordinal

3

1 reference

24 August 2017

Alberta Leon

series ordinal

4

1 reference

24 August 2017

publication date

1 May 2011

1 reference

24 August 2017

published in

Neurological Sciences

1 reference

24 August 2017

volume

32 Suppl 1

1 reference

24 August 2017

page(s)

S121-9

1 reference

The prevalence and characteristics of migraine in a population-based cohort: the GEM study

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Focal hyperemia followed by spreading oligemia and impaired activation of rcbf in classic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Pathogenesis of migraine: from neurotransmitters to neuromodulators and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

The occipital cortex is hyperexcitable in migraine: experimental evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

The human platelet as a model for the glutamatergic neuron: platelet uptake of L-glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Platelet Glycine, Glutamate and Aspartate in Primary Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Excitatory neurotransmitters in brain regions in interictal migraine patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Platelet secretion from dense and alpha-granules in vitro in migraine with or without aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Platelet-activating factor (PAF) in internal jugular venous blood of migraine without aura patients assessed during migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Platelet Models and Their Possible Usefulness in the Study of Migraine Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Prevalence of atrial septal aneurysm in patients with migraine: an echocardiographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Treatment of migraine with aura: comments and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Clinical trial of nimodipine for single attacks of classic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Sumatriptan in the Treatment of Acute Migraine With Aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Subcutaneous sumatriptan during the migraine aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Ergotamine and cerebral blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Reversible cerebral arteriopathy associated with the administration of ergot derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

A prospective study of migraine with aura attacks in a headache clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Classic migraine: effective prophylaxis with metoprolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Symptoms of Classic Migraine Attacks: Modifications Brought about by Metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Lamotrigine in the prophylactic treatment of migraine aura--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Persistent migrainous visual phenomena might be responsive to lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Migraine with aura triggered by orgasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Preventing disturbing migraine aura with lamotrigine: an open study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Antiepileptic drugs: how they work in headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Efficacy of topiramate in migraine aura prophylaxis: preliminary results of 12 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Picotamide in migraine aura prevention: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Ginkgolide B, a constituent of Ginkgo biloba, facilitates glutamate exocytosis from rat hippocampal nerve terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 520211

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Inhibition of platelet-activating factor receptors in hippocampal plasma membranes attenuates the inflammatory nociceptive response in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Ginkgo biloba leaf extract: review of biological actions and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Evidence for a vagal pathophysiology for bulimia nervosa and the accompanying depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Efficacy of Ginkgolide B in the prophylaxis of migraine with aura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Competitive inhibition of platelet thromboxane A2 receptor binding by picotamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10072-011-0529-0

Perfusion weighted imaging during migraine: spontaneous visual aura and headache

21 January 2018

1 reference

12 December 2020

Lamotrigine versus placebo in the prophylaxis of migraine with and without aura

1 reference

12 December 2020

Hyperexcitability of the primary somatosensory cortex in migraine--a magnetoencephalographic study

1 reference

12 December 2020

Prophylactic treatment of classical and non-classical migraine with metoprolol--a comparison with placebo

1 reference

12 December 2020

Migraine as a defect of brain oxidative metabolism: a hypothesis

1 reference

12 December 2020

Plasma cytokine levels in migraineurs and controls

1 reference

12 December 2020

The International Classification of Headache Disorders: 2nd edition

1 reference

12 December 2020

Treatment of complicated migraine with sublingual nifedipine

1 reference

12 December 2020

Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study

1 reference

12 December 2020

Treatment of aura: solving the puzzle.

1 reference

12 December 2020

Platelet and Plasma Levels of Glutamate and Glutamine in Migraine With and Without Aura

1 reference

12 December 2020

Acetazolamide treatment for migraine aura status

1 reference

12 December 2020

Treatment of a prolonged migrainous aura with intravenous furosemide

1 reference

12 December 2020

Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study

1 reference

12 December 2020

Sensitivity to PAF is increased in migraine patients

1 reference

12 December 2020

Platelet Activity in Migraine

1 reference

12 December 2020

Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation

1 reference

12 December 2020

Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration

1 reference

12 December 2020

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

12 December 2020

Ginkgolide B and bilobalide block the pore of the 5-HT₃receptor at a location that overlaps the picrotoxin binding site

1 reference

12 December 2020

Pharmacological action and mechanisms of ginkgolide B.

1 reference

12 December 2020

10.1007/S10072-011-0529-0

Identifiers

DOI

1 reference

24 August 2017

1 reference